Cost analysis of therapy for patients with multiple sclerosis (MS) in Poland.

@article{Matschay2008CostAO,
  title={Cost analysis of therapy for patients with multiple sclerosis (MS) in Poland.},
  author={Arleta Matschay and Elżbieta Nowakowska and Hanka Hertmanowska and Krzysztof Kus and Anna Czubak},
  journal={Pharmacological reports : PR},
  year={2008},
  volume={60 5},
  pages={632-44}
}
Multiple sclerosis (MS) is a neurological disease of the central nervous system in which dissipated demyelination lesions develop. The currently available pharmacotherapy and rehabilitation for this disease aims to preserve the patients' physical abilities and prevent disease progression and nervous system damage. The study evaluated the direct and indirect costs associated with two different treatment regimens for multiple sclerosis diagnosed patients by comparing two groups of 60 subjects… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 46 references

A et al.: The cost of multiple sclerosis: a cross-sectional, multicenter cost-of-illness study in Italy

  • MP Amato, MA Battaglia, +4 authors Reggio
  • J Neurol,
  • 2002
Highly Influential
5 Excerpts

MS patient survey cost and reimbursement of treatment

  • L McGown, L McWhinnie
  • The cost of multiple scleroPharmacological…
  • 2008
1 Excerpt

Economic evaluation of Avonex ® ( interferon betaIa ) in patients following a single demyelinating event

  • LD Jacobs, RW Beck, JH Simon, LP Kinkel, TJ Murray, NA Simonian
  • Mult Scler
  • 2005

The cost of multiple sclerosis : a cross - sectional , multicenter costofillness study in Italy

  • MP Amato, MA Battaglia, +4 authors A Reggio
  • J Neurol
  • 2002

Similar Papers

Loading similar papers…